65 related articles for article (PubMed ID: 23907410)
1. Detection of nucleophosmin and FMS-like tyrosine kinase-3 gene mutations in acute myeloid leukemia.
Pazhakh V; Zaker F; Alimoghaddam K; Atashrazm F
Ann Saudi Med; 2011; 31(1):45-50. PubMed ID: 21245599
[TBL] [Abstract][Full Text] [Related]
2. The Clinical Utility of
Bergeron J; Capo-Chichi JM; Tsui H; Mahe E; Berardi P; Minden MD; Brandwein JM; Schuh AC
Curr Oncol; 2023 Dec; 30(12):10410-10436. PubMed ID: 38132393
[TBL] [Abstract][Full Text] [Related]
3. Measurable Residual
Gui G; Dillon LW; Ravindra N; Hegde PS; Andrew G; Mukherjee D; Wong Z; Auletta J; El Chaer F; Chen E; Chen YB; Corner A; Devine SM; Iyer S; Jimenez Jimenez AM; De Lima MJG; Litzow MR; Kebriaei P; Spellman SR; Zeger SL; Page KM; Hourigan CS
medRxiv; 2023 Aug; ():. PubMed ID: 37577695
[TBL] [Abstract][Full Text] [Related]
4. Can novel methods replace the gold standard chimerism method after allogeneic hematopoietic stem cell transplantation?
Sel FA; Oğuz FS
Ann Hematol; 2024 Apr; 103(4):1035-1047. PubMed ID: 37801085
[TBL] [Abstract][Full Text] [Related]
5. Transplant in AML: just follow the NPM1 guide!
Récher C
Blood; 2024 May; 143(19):1881-1882. PubMed ID: 38722660
[No Abstract] [Full Text] [Related]
6. A comprehensive case study on successful multimodal therapy in philadelphia chromosome-positive acute myeloid leukemia with
Haider SMW; Zehra M; Shah NN; Sotomayor EM; Swoboda DM
Leuk Res Rep; 2024; 21():100461. PubMed ID: 38736691
[TBL] [Abstract][Full Text] [Related]
7. Mixed chimerism post allogeneic stem cell transplant for Chediak-Higashi syndrome-Clues from morphology and blood banking.
McKeague S; O'Rourke K; Adams R; Harvey Y; Keng TB; Kennedy G
Br J Haematol; 2024 May; 204(5):1571-1572. PubMed ID: 38471714
[No Abstract] [Full Text] [Related]
8. Quantifying
Schwind S; Bischof L; Bill M; Grimm J; Ussmann J; Backhaus D; Brauer D; Thanh TP; Merz M; Franke GN; Metzeler KH; Vucinic V; Herling M; Platzbecker U; Jentzsch M
Hemasphere; 2024 Mar; 8(3):e55. PubMed ID: 38501048
[No Abstract] [Full Text] [Related]
9. Hematopoietic transplantation for acute myeloid leukemia with internal tandem duplication of FLT3 gene (FLT3/ITD).
Brunet S; Martino R; Sierra J
Curr Opin Oncol; 2013 Mar; 25(2):195-204. PubMed ID: 23385863
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic stem cell transplantation and targeted therapy for FLT3/ITD+ acute myeloid leukemia: an update.
Hu B; Vikas P; Mohty M; Savani BN
Expert Rev Hematol; 2014 Apr; 7(2):301-15. PubMed ID: 24308526
[TBL] [Abstract][Full Text] [Related]
11. A fast and simple approach for the simultaneous detection of hematopoietic chimerism, NPM1, and FLT3-ITD mutations after allogeneic stem cell transplantation.
Waterhouse M; Bertz H; Finke J
Ann Hematol; 2014 Feb; 93(2):293-8. PubMed ID: 23907410
[TBL] [Abstract][Full Text] [Related]
12. Role of autologous hematopoietic stem cell transplantation according to the NPM1/FLT3-ITD molecular status for cytogenetically normal AML patients: a GOELAMS study.
Guièze R; Cornillet-Lefebvre P; Lioure B; Blanchet O; Pigneux A; Recher C; Bonmati C; Fegueux N; Bulabois CE; Bouscary D; Vey N; Delain M; Turlure P; Himberlin C; Harousseau JL; Dreyfus F; Béné MC; Ifrah N; Chevallier P;
Am J Hematol; 2012 Dec; 87(12):1052-6. PubMed ID: 22911473
[TBL] [Abstract][Full Text] [Related]
13. Clinical impact of nucleophosmin mutations and Flt3 internal tandem duplications in patients older than 60 yr with acute myeloid leukaemia.
Scholl S; Theuer C; Scheble V; Kunert C; Heller A; Mügge LO; Fricke HJ; Höffken K; Wedding U
Eur J Haematol; 2008 Mar; 80(3):208-15. PubMed ID: 18081718
[TBL] [Abstract][Full Text] [Related]
14. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.
Schlenk RF; Döhner K; Krauter J; Fröhling S; Corbacioglu A; Bullinger L; Habdank M; Späth D; Morgan M; Benner A; Schlegelberger B; Heil G; Ganser A; Döhner H;
N Engl J Med; 2008 May; 358(18):1909-18. PubMed ID: 18450602
[TBL] [Abstract][Full Text] [Related]
15. FLT3 and NPM1 mutations in a cohort of AML patients and detection of a novel mutation in tyrosine kinase domain of FLT3 gene from Western India.
Ghosh K; Swaminathan S; Madkaikar M; Gupta M; Kerketta L; Vundinti B
Ann Hematol; 2012 Nov; 91(11):1703-12. PubMed ID: 22733614
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
